查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
下一代測序服務市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測，按服務、工作流程、最終用戶、地區和競爭細分
市場調查報告書
商品編碼
1326508

下一代測序服務市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測，按服務、工作流程、最終用戶、地區和競爭細分

Next Generation Sequencing Services Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Service, By Workflow, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球下一代測序服務市場預計在 2024-2028 年預測期內將出現令人印象深刻的成長。這種成長是由於基因組技術的進步、對精準醫療的需求不斷增加、下一代測序在臨床研究中的應用不斷增加以及遺傳性疾病患病率的增加而造成的。

發展中國家擴大採用 NGS

近年來，發展中國家對下一代測序（NGS）技術的採用一直在穩步增加。預計這一趨勢將在未來幾年持續下去，並對 NGS 市場的成長產生重大影響。推動發展中國家採用 NGS 的主要因素之一是對更好的醫療服務的需求不斷成長。 NGS技術有潛力改善各種疾病的診斷和治療，包括遺傳性疾病、癌症和傳染病。隨著發展中國家面臨著日益沉重的這些疾病負擔，NGS 正在成為其醫療保健系統的重要工具。

此外，NGS技術成本的下降和負擔得起的測序平台的可用性使得發展中國家更容易採用該技術。此外，許多發展中國家的政府正在投資發展其醫療保健基礎設施，其中包括採用 NGS 等先進技術。 NGS 在發展中國家的日益普及預計將成為未來幾年 NGS 市場成長的主要推動力。對更好的醫療保健服務不斷成長的需求、NGS 技術成本的下降以及政府對醫療保健基礎設施的投資是推動這一趨勢的關鍵因素。

基因組技術的進步

基因組技術的進步正在推動未來幾年下一代測序 (NGS) 市場的成長。基因組技術的發展使得以更快的速度、更高的準確性和更低的成本對 DNA 和 RNA 進行測序成為可能。這導致NGS技術在臨床研究、藥物發現、個性化醫療和農業等各個領域得到廣泛採用。

基因組技術的重大進步之一是長讀長測序技術的發展。長讀長測序可提供長 DNA 和 RNA 片段的完整測序，這對於理解結構變異、基因融合和選擇性剪接等複雜的遺傳變異至關重要。該技術提高了基因組組裝的準確性和完整性，使得識別新的遺傳變異並增進對疾病遺傳基礎的理解成為可能。

基因組技術的另一個進步是單細胞測序技術的發展。該技術可以分析單個細胞，從而深入了解細胞異質性和細胞相互作用。單細胞測序正在應用於各個領域，包括癌症研究、神經生物學和發育生物學。因此，這些領域對 NGS 技術的需求不斷成長。

此外，雲端基礎計算平台和生物資訊學工具的發展使得分析NGS數據變得更加容易，從而導致NGS市場的成長。這些工具使研究人員能夠快速有效地分析大規模基因組資料集，從而獲得新的發現並改善患者的治療結果。

基因組技術的進步正在推動未來幾年 NGS 市場的成長。長讀長測序、單細胞測序和雲端基礎計算平台是塑造 NGS 市場未來的一些關鍵進步。

遺傳性疾病患病率不斷增加

遺傳性疾病患病率的增加是未來幾年推動下一代測序（NGS）市場成長的重要因素。遺傳性疾病是由個體 DNA 序列異常引起的，可能導致多種健康問題。一些常見的遺傳性疾病包括囊性纖維化、鐮狀細胞性貧血和亨廷頓病。

NGS 技術允許對大部分人類基因組進行快速且經濟有效的測序，從而徹底改變了遺傳學領域。這項技術使得識別導致各種遺傳疾病的基因突變和變異成為可能。因此，NGS 已成為基因研究和臨床診斷的重要工具。

遺傳性疾病的患病率日益增加，推動了臨床診斷中對 NGS 技術的需求。基於NGS的基因檢測可以為遺傳性疾病患者提供準確、全面的診斷，使醫生能夠提供更個性化、更有效的治療方案。此外，基於NGS的基因檢測變得越來越便宜和容易獲得，使更多患者有可能從這項技術中受益。

除了臨床診斷之外，NGS 技術還被用於基因研究，以識別與各種疾病相關的新基因突變和變異。這項研究對於開發遺傳性疾病的新療法和療法至關重要。遺傳性疾病患病率的增加預計將成為未來幾年 NGS 市場成長的重要驅動力。 NGS 技術能夠對大部分人類基因組進行快速且經濟高效的測序，從而使遺傳學領域發生了革命性的變化，從而使識別導致各種遺傳疾病的基因突變和變異成為可能。

可用的客製化：

根據給定的市場數據，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自定義選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 考慮學習的年份
    • 主要市場細分

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要行業合作夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球下一代測序服務市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按服務分類（人類基因組測序服務、單細胞測序服務、微生物基因組測序服務、基因調控服務、其他）
    • 按工作流程（預測序、測序、數據分析）
    • 按最終用戶（醫院和診所、學術和研究機構、製藥和生物技術公司、其他）
    • 按地區
    • 按公司分類 (2022)
  • 產品圖
    • 按服務
    • 按工作流程
    • 按最終用戶
    • 按地區

第 6 章：北美下一代測序服務市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按服務
    • 按工作流程
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲下一代測序服務市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按服務
    • 按工作流程
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區下一代測序服務市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按服務
    • 按工作流程
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第 9 章：南美洲下一代測序服務市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按服務
    • 按工作流程
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲下一代測序服務市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按服務
    • 按工作流程
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非下一代測序服務
    • 沙烏地阿拉伯下一代測序服務
    • 阿拉伯聯合大公國下一代測序服務

第 11 章：市場動態

  • 司機
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球下一代測序服務市場：SWOT 分析

第 14 章：波特的五力分析

  • 行業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 服務內容
  • 最近的發展
  • 主要人員
  • SWOT分析
    • Quest Diagnostics Incorporated
    • Applied Biological Materials, Inc.
    • Novogene Co, Ltd.
    • Azenta Life Sciences (GENEWIZ)
    • NanoString Technologies, Inc.
    • Illumina, Inc.
    • PacBio, Inc.
    • Gene by Gene Ltd
    • Lucigen Corporation

第 16 章：戰略建議

簡介目錄
Product Code: 15173

Global Next Generation Sequencing Services Market is expected to see impressive growth during the forecast period, 2024-2028. This growth is accounted for by advancements in genomic technologies, increasing demand for precision medicine, growing application of next-generation sequencing in clinical research, and increasing prevalence of genetic disorders.

Advancements in genomic technologies have led to the development of more advanced and efficient sequencing platforms, which have reduced the cost and time required for sequencing. This has made NGS more accessible to researchers and has driven the growth of the NGS Services Market.

The demand for precision medicine has increased significantly in recent years as researchers and healthcare providers seek to develop personalized treatments for patients based on their unique genetic makeup. NGS services are essential for identifying genetic variations that may be relevant to disease diagnosis, prognosis, and treatment.

NGS is increasingly being used in clinical research, including clinical trials and diagnostic testing. This has led to a growing demand for NGS services in the clinical research industry.

The increasing prevalence of genetic disorders has driven the growth of the NGS Services Market. NGS can be used to diagnose genetic disorders and identify potential treatments, making it an essential tool for genetic testing and diagnosis.

In the past few years, several new NGS services have been launched in the market. For example, in 2020, Illumina launched the NovaSeq 6000 system, which is designed to offer high-throughput sequencing with low per-sample costs. The system uses innovative flow cells and sequencing reagents to deliver high accuracy and cost-effectiveness, making it an attractive option for large-scale sequencing projects.

Thermo Fisher Scientific launched the Ion GeneStudio S5 system in 2019, which is designed to enable fast and accurate NGS for a range of applications. The system offers a compact and scalable design, making it suitable for a range of settings, from small labs to large-scale research facilities. In 2019, Qiagen launched the QIAseq Targeted RNA Panels, which enable researchers to analyze specific gene targets for RNA sequencing. The panels are designed to be compatible with the company's GeneReader NGS system, allowing for a streamlined workflow from sample to result.

However, the market of next-generation sequencing will face several challenges, including data management and analysis, standardization and quality control, regulatory challenges, cost, and data privacy and security. The biggest challenge associated with NGS services is the sheer volume of data generated by the sequencing process. Processing and analyzing this data can be time-consuming and computationally intensive, requiring specialized software and hardware. In addition, the accuracy of the results can be affected by various factors such as sequencing errors, sample contamination, and reference genome quality.

Standardization and quality control are essential to ensure the accuracy and reliability of NGS results. However, there are currently no universally accepted standards for NGS, and quality control can be challenging due to the high variability of samples and sequencing technologies. There is a need for robust quality control procedures that can be applied across different sequencing platforms and laboratories.

Increasing Adoption of NGS in Developing Countries

The adoption of Next Generation Sequencing (NGS) technology in developing countries has been steadily increasing in recent years. This trend is expected to continue in the coming years, and it will have a significant impact on the growth of the NGS market. One of the major factors driving the adoption of NGS in developing countries is the increasing demand for better healthcare services. NGS technology has the potential to improve the diagnosis and treatment of various diseases, including genetic disorders, cancer, and infectious diseases. As developing countries are facing a growing burden of these diseases, NGS is becoming an essential tool for their healthcare systems.

Moreover, the declining cost of NGS technology and the availability of affordable sequencing platforms are making it easier for developing countries to adopt this technology. Additionally, many governments in developing countries are investing in the development of their healthcare infrastructure, which includes the adoption of advanced technologies like NGS. The increasing adoption of NGS in developing countries is expected to be a major driver for the growth of the NGS market in the coming years. The growing demand for better healthcare services, declining costs of NGS technology, and government investments in healthcare infrastructure are the key factors driving this trend.

Advancements in Genomic Technologies

Advancements in genomic technologies are driving the growth of the Next Generation Sequencing (NGS) Market in the coming years. The evolution of genomic technologies has made it possible to sequence DNA and RNA at a faster pace, with greater accuracy, and at a lower cost. This has led to the widespread adoption of NGS technology in various fields, including clinical research, drug discovery, personalized medicine, and agriculture.

One of the significant advancements in genomic technologies is the development of long-read sequencing technology. Long-read sequencing provides complete sequencing of long DNA and RNA fragments, which is critical for understanding complex genetic variations such as structural variants, gene fusions, and alternative splicing. This technology has improved the accuracy and completeness of genome assemblies, making it possible to identify new genetic variants and improve understanding of the genetic basis of diseases.

Another advancement in genomic technologies is the development of single-cell sequencing technology. This technology allows the analysis of individual cells, providing insight into cellular heterogeneity and cellular interactions. Single-cell sequencing is being used in various fields, including cancer research, neurobiology, and developmental biology. As a result, there is a growing demand for NGS technology in these areas.

In addition, the development of cloud-based computing platforms and bioinformatics tools has made it easier to analyze NGS data, leading to the growth of the NGS market. These tools allow researchers to analyze large-scale genomic data sets quickly and efficiently, leading to new discoveries and improved patient outcomes.

Advancements in genomic technologies are driving the growth of the NGS Market in the coming years. Long-read sequencing, single-cell sequencing, and cloud-based computing platforms are some of the key advancements that are shaping the future of the NGS market.

Increasing Prevalence of Genetic Disorders

The increasing prevalence of genetic disorders is a significant factor driving the growth of the Next Generation Sequencing (NGS) market in the coming years. Genetic disorders are caused by abnormalities in an individual's DNA sequence, and they can result in a wide range of health problems. Some of the common genetic disorders include cystic fibrosis, sickle cell anemia, and Huntington's disease.

NGS technology has revolutionized the field of genetics by allowing for the rapid and cost-effective sequencing of large portions of the human genome. This technology has made it possible to identify the genetic mutations and variations that are responsible for various genetic disorders. As a result, NGS has become an essential tool for genetic research and clinical diagnostics.

The increasing prevalence of genetic disorders is driving the demand for NGS technology in clinical diagnostics. NGS-based genetic testing can provide accurate and comprehensive diagnoses for patients with genetic disorders, enabling doctors to provide more personalized and effective treatment plans. Moreover, NGS-based genetic testing is becoming increasingly affordable and accessible, making it possible for more patients to benefit from this technology.

In addition to clinical diagnostics, NGS technology is being used in genetic research to identify new genetic mutations and variations associated with various diseases. This research is critical for developing new treatments and therapies for genetic disorders. The increasing prevalence of genetic disorders is expected to be a significant driver for the growth of the NGS Market in the coming years. NGS technology has revolutionized the field of genetics by enabling the rapid and cost-effective sequencing of large portions of the human genome, making it possible to identify the genetic mutations and variations responsible for various genetic disorders.

Market Segmentation

Global Next Generation Sequencing Services Market can be segmented based on service, workflow, end user, and region. Based on service, the market can be divided into human genome sequencing services, single-cell sequencing services, microbial genome-based sequencing services, gene regulation services, and others. Based on workflow, the market is divided into pre-sequencing, sequencing, and data analysis. Based on end users, the market is divided into hospitals & clinics, academic & research institutions, pharmaceutical & biotechnology companies, and others. Regionally, the Next Generation Sequencing Services Market can be categorized into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

Quest Diagnostics Incorporated, Applied Biological Materials, Inc., Novogene Co, Ltd., Azenta Life Sciences (GENEWIZ), NanoString Technologies, Inc., Illumina, Inc., PacBio, Inc., Gene by Gene Ltd, Lucigen Corporation are some of the leading players operating in the Global Next Generation Sequencing Services Market.

Report Scope:

In this report, Global Next Generation Sequencing Services Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Next Generation Sequencing Services Market, By Service:

  • Human Genome Sequencing Services
  • Single Cell Sequencing Services
  • Microbial Genome-based Sequencing Services
  • Gene Regulation Services
  • Others

Next Generation Sequencing Services Market, By Workflow:

  • Pre-Sequencing
  • Sequencing
  • Data Analysis

Next Generation Sequencing Services Market, By Workflow:

  • Hospitals & Clinics
  • Academic & Research Institutions
  • Pharmaceutical & Biotechnology Companies
  • Others

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Next Generation Sequencing Services Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Next Generation Sequencing Services Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service (Human Genome Sequencing Services, Single Cell Sequencing Services, Microbial Genome-based Sequencing Services, Gene Regulation Services, Others)
    • 5.2.2. By Workflow (Pre-Sequencing, Sequencing, Data Analysis)
    • 5.2.3. By End User (Hospitals & Clinics, Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Product Map
    • 5.3.1. By Service
    • 5.3.2. By Workflow
    • 5.3.3. By End User
    • 5.3.4. By Region

6. North America Next Generation Sequencing Services Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service
    • 6.2.2. By Workflow
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Next Generation Sequencing Services Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service
        • 6.3.1.2.2. By Workflow
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Next Generation Sequencing Services Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service
        • 6.3.2.2.2. By Workflow
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Next Generation Sequencing Services Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service
        • 6.3.3.2.2. By Workflow
        • 6.3.3.2.3. By End User

7. Europe Next Generation Sequencing Services Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service
    • 7.2.2. By Workflow
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Next Generation Sequencing Services Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service
        • 7.3.1.2.2. By Workflow
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Next Generation Sequencing Services Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service
        • 7.3.2.2.2. By Workflow
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Next Generation Sequencing Services Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Service
        • 7.3.3.2.2. By Workflow
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Next Generation Sequencing Services Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Service
        • 7.3.4.2.2. By Workflow
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Next Generation Sequencing Services Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Service
        • 7.3.5.2.2. By Workflow
        • 7.3.5.2.3. By End User

8. Asia-Pacific Next Generation Sequencing Services Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service
    • 8.2.2. By Workflow
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Next Generation Sequencing Services Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service
        • 8.3.1.2.2. By Workflow
        • 8.3.1.2.3. By End User
    • 8.3.2. India Next Generation Sequencing Services Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service
        • 8.3.2.2.2. By Workflow
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Next Generation Sequencing Services Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service
        • 8.3.3.2.2. By Workflow
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Next Generation Sequencing Services Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service
        • 8.3.4.2.2. By Workflow
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Next Generation Sequencing Services Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service
        • 8.3.5.2.2. By Workflow
        • 8.3.5.2.3. By End User

9. South America Next Generation Sequencing Services Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service
    • 9.2.2. By Workflow
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Next Generation Sequencing Services Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service
        • 9.3.1.2.2. By Workflow
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Next Generation Sequencing Services Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service
        • 9.3.2.2.2. By Workflow
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Next Generation Sequencing Services Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service
        • 9.3.3.2.2. By Workflow
        • 9.3.3.2.3. By End User

10. Middle East and Africa Next Generation Sequencing Services Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service
    • 10.2.2. By Workflow
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Next Generation Sequencing Services Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service
        • 10.3.1.2.2. By Workflow
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Next Generation Sequencing Services Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service
        • 10.3.2.2.2. By Workflow
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Next Generation Sequencing Services Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service
        • 10.3.3.2.2. By Workflow
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Next Generation Sequencing Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Quest Diagnostics Incorporated
    • 15.5.2. Applied Biological Materials, Inc.
    • 15.5.3. Novogene Co, Ltd.
    • 15.5.4. Azenta Life Sciences (GENEWIZ)
    • 15.5.5. NanoString Technologies, Inc.
    • 15.5.6. Illumina, Inc.
    • 15.5.7. PacBio, Inc.
    • 15.5.8. Gene by Gene Ltd
    • 15.5.9. Lucigen Corporation

16. Strategic Recommendations